The phrase "agents in developing" is correct and usable in written English.
It can be used in contexts where you are referring to individuals or entities that play a role in the process of development, such as in projects, policies, or social changes.
Example: "The organization acts as agents in developing sustainable practices within the community."
Alternatives: "participants in fostering" or "actors in advancing".
These compounds could potentially serve as templates for future drug-optimization and drug-development efforts for their use as therapeutic agents in developing countries.
Organisms such as sexually transmitted Chlamydia trachomatas and Nissera gonorrhoea are causative agents in developing ascending cervicitis.
The tubo-ovarian abscess may be due to dissemination of infection by organisms, such as sexually transmitted Chlamydia trachomatis and Neisseria gonorrhoeae, that are causative agents in developing ascending cervicitis with involvement and incorporation of the fallopian tubes and ovaries [41].
With this cheap and simple tool, border agents in developing nations will be able identify and shut down traffickers more easily.
These clinical observations may lead us to examine further the role of antioxidant agents in developing novel therapies for septic shock.
(Malvaceae) and suggests that this herbaceous possess compounds with high antibacterial properties that can be used as antibacterial agents in developing new drugs for the therapy of infectious diseases caused by pathogenic bacteria.
Instead, halothane is the most widely used volatile agent in developing nations [ 8].
Thus, NAC may be a safe therapeutic agent in pregnant women to decrease the levels of this toxic agent in developing embryos.
It was also reported that subsequent cooperation from the PUNs could have been more engaged in support of UNICEF, as the Managing Agent, in developing the programme.
This study demonstrates the importance of choice of anaesthetic agent in developing a safe and effective pre-hospital trauma RSI protocol.
The mutant hFasLECD containing the reactive cysteine residue conjugable to maleimide group containing compounds should also become a powerful molecular agent in developing devices for quantifying such disease specific biomarkers.
